Health
Spacing COVID-19 vaccine doses has benefits, but longer-term outcomes depend on robust immunity – Medical Xpress
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral…
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral “escape” from immunity will depend on the robustness of immune responses generated by natural infections and one or two vaccine doses, according to a Princeton University and McGill University study published March 9 in the journal Science.
“Several countries including the United Kingdom and Canada have stated that they will delay second…
-
Noosa News21 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business23 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Business19 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
General23 hours agoLike ‘déjà vu’ all over again?